259 related articles for article (PubMed ID: 4916084)
41. Estrogen and survival data in carcinoma of the prostate.
Bennett AH; Dowd JB; Harrison JH
Surg Gynecol Obstet; 1970 Mar; 130(3):505-8. PubMed ID: 4905115
[No Abstract] [Full Text] [Related]
42. Lymph node involvement in prostatic carcinoma.
Varkarakis MJ; Murphy GP; Nelson CM; Chehval M; Moore RH; Flocks RH
Urol Clin North Am; 1975 Feb; 2(1):197-212. PubMed ID: 1128748
[No Abstract] [Full Text] [Related]
43. The contemporary value of pretreatment prostatic acid phosphatase to predict pathological stage and recurrence in radical prostatectomy cases.
Moul JW; Connelly RR; Perahia B; McLeod DG
J Urol; 1998 Mar; 159(3):935-40. PubMed ID: 9474187
[TBL] [Abstract][Full Text] [Related]
44. Preoperative endocrine therapy in patients with locally advanced prostate cancer.
Maeda O; Meguro N; Saiki S; Kinouchi T; Kuroda M; Usami M; Kotake T
Jpn J Clin Oncol; 1995 Aug; 25(4):135-9. PubMed ID: 7545250
[TBL] [Abstract][Full Text] [Related]
45. Status of the treatment of prostatic carcinoma--1964.
Prout GR
Proc Natl Cancer Conf; 1964; 5():309. PubMed ID: 5889426
[No Abstract] [Full Text] [Related]
46. [Enzymological study of prostatic cancer. I. Changes of serum lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, total acid phosphatase, prostatic acid phosphatase, glutamic pyruvic transaminase, glutamic oxalacetic transaminase activity and lactic dehydrogenase isoenzymes in prostatic cancer under anti-androgenic treatment, with special reference to prognosis].
Ishibe T; Matsuki A; Nihira H
Hinyokika Kiyo; 1969 Mar; 15(3):195-205. PubMed ID: 5814574
[No Abstract] [Full Text] [Related]
47. Current status of estrogen therapy for prostatic carcinoma.
Blackard CE; Mellinger GT
Postgrad Med; 1972 Mar; 51(3):140-5. PubMed ID: 4553219
[No Abstract] [Full Text] [Related]
48. Endocrine treatment of prostate cancer: standard treatment and new perspectives.
Boccardo F; Pace M
In Vivo; 1993; 7(5):423-4. PubMed ID: 8110985
[TBL] [Abstract][Full Text] [Related]
49. Combination of hormonal and cytostatic treatment for advanced carcinoma of the prostate.
Servadio C
Prog Clin Biol Res; 1985; 185A():407-26. PubMed ID: 4034582
[No Abstract] [Full Text] [Related]
50. Current concepts concerning carcinoma of the prostate.
Skinner DG
Surg Annu; 1973; 5():393-406. PubMed ID: 4602222
[No Abstract] [Full Text] [Related]
51. [Adjuvant treatment of prostatic carcinoma after primary therapy. The "Early Prostate Cancer" Program].
Mansueto G; Longo F
Recenti Prog Med; 2002 Mar; 93(3):175-8. PubMed ID: 11942169
[No Abstract] [Full Text] [Related]
52. Effect of diethylstilbestrol on blood glucose of prostatic cancer patients.
Sotaniemi EA; Kontturi M; Larmi TK
Invest Urol; 1973 May; 10(6):438-41. PubMed ID: 4704169
[No Abstract] [Full Text] [Related]
53. Carcinoma of the prostate: reasons for endocrine treatment prior to symptomatic metastases.
Chisholm GD
Prog Clin Biol Res; 1990; 359():1-6; discussion 15-24. PubMed ID: 2284285
[No Abstract] [Full Text] [Related]
54. A highly successful approach to operable prostate cancer in a community hospital.
Spagnola NR; Paul WT; Smith JP; Saylor M
Ohio State Med J; 1981 Aug; 77(8):503-6. PubMed ID: 7279364
[No Abstract] [Full Text] [Related]
55. The role of radical prostatectomy in patients with clinically localized prostate cancer and a prostate-specific antigen level >20 ng/ml.
Bastide C; Kuefer R; Loeffler M; de Petriconi R; Gschwend J; Hautmann R
Prostate Cancer Prostatic Dis; 2006; 9(3):239-44. PubMed ID: 16832384
[TBL] [Abstract][Full Text] [Related]
56. Carcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Examined by the step-section technique.
Byar DP; Mostofi FK
Cancer; 1972 Jul; 30(1):5-13. PubMed ID: 5064808
[No Abstract] [Full Text] [Related]
57. Endocrine approaches in the therapy of prostate carcinoma.
d'Ancona FC; Debruyne FM
Hum Reprod Update; 2005; 11(3):309-17. PubMed ID: 15790600
[TBL] [Abstract][Full Text] [Related]
58. Treatment of advanced carcinoma of the prostate.
Blackard CE
Surg Gynecol Obstet; 1971 Jul; 133(1):97-8. PubMed ID: 5091832
[No Abstract] [Full Text] [Related]
59. The possible role of transurethral resection in the dissemination of prostatic cancer.
Bandhauer K
Eur Urol; 1975; 1(6):272-4. PubMed ID: 1233194
[TBL] [Abstract][Full Text] [Related]
60. [Chemotherapy of advanced prostate cancer].
Murphy GP
Vopr Onkol; 1977; 23(12):26-38. PubMed ID: 146305
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
